The first pillar is advanced manufacturing, focused on upgrading existing CDMO
Guidelines aim to establish state-regulated veterinary blood banks
The $700 million project is part of Roche’s $50 billion investment in US manufacturing, infrastructure and R&D
KER-065 is a novel ligand trap comprised of a modified ligand-binding domain derived from activin receptor type IIA and activin receptor type IIB
Dawnzera demonstrated significant and sustained HAE attack rate reduction and long-term disease control
The company has improved access to quality healthcare for seniors across both urban and rural areas
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Subscribe To Our Newsletter & Stay Updated